lthough it has been known for ≈50 years that the size of a myocardial infarction (MI) can be modulated by medications and other interventions, reperfusion by fibrinolysis or percutaneous coronary intervention remains the only treatment known to reduce infarct size in patients. 1 Although many pharmacological treatments reduce infarct size in animal models, the overwhelming majority have failed in human clinical trials. The concept that cardiac magnetic resonance (CMR) could retrospectively image myocardium at risk (MaR), measure infarct size, and determine myocardial salvage in an examination conveniently 2 days after reperfusion 2 was intriguing and garnered much attention over the past decade. However, with scrutiny, the simple explanation of why myocardial T2 could detect the area at risk in acute MI as edematous tissue has turned out to be more complicated and controversial. However, it seems clear that these magnetic resonance imaging (MRI) methods are providing insight into the pathophysiology of acute MI. Beyond methodological issues, which are fundamental to the field, it is important for clinicians and scientists to recognize that edema modulates the relationship between area at risk and infarct size, and thus one needs to interpret these measurements carefully regardless of the method used.
In this issue of Circulation, Fernández-Jiménez et al 3 describe that a bimodal temporal course of myocardial T2 occurs in patients after reperfused acute MI-an important extension beyond their previous preclinical experiments. Their group was the first to notice that myocardial edema after ischemia/reperfusion goes through a bimodal pattern with a wave of substantial edema on the day of the infarct, a decline in edema 24 hours after reperfusion, and a rebound in edema 4 to 7 days after MI. 4 They related these 2 waves of edema to reperfusion injury and the healing process after MI in a subsequent study. 5 As measured, in the porcine model of acute MI in the current study, Fernán-dez-Jiménez et al 3 find that the CMR-MaR 24 hours after reperfusion severely underestimates the infarct size and produces incongruous negative values for myocardial salvage (salvage should not be <0). CMR-MaR is still smaller than the infarct 4 days after MI, resulting in negative estimates of myocardial salvage at that time as well.
Recognizing that the bimodal temporal variation in T2 and CMR-MaR also occurs in people is clearly an important step forward in our understanding of ischemia and reperfusion injury. It is a little harder to interpret some aspects of the human findings because infarct size was imaged only on day 7 to avoid exposing patients to unnecessary gadolinium doses and simplify imaging. Nonetheless, it is intriguing that the human CMR-MaR appears relatively consistent at ≤3 hours, 4 days, and 7 days but clearly underestimates the MaR 24 hours after reperfusion.
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Other aspects of the current preclinical experiments 3 highlight our incomplete understanding of the importance of myocardial edema when interpreting infarct size and myocardial salvage. A contrast-enhanced CT scan of the heart was performed during the original coronary artery occlusion as the reference standard for MaR. With such a high-resolution, 3-dimensional image of the perfusion defect, how can one expect a better determination of the MaR? In fact, this metric of the MaR is probably the best with respect to the preischemic myocardial mass.
Yet how does the multidetector-CT perfusion defect size compare with the ultimate infarct size in these experiments? When used to determine myocardial salvage in the porcine model where infarct size was determined on each terminal day of the experiment, the multidetector-CT-MaR underestimates the ultimate infarct size at all time points from 120 minutes through 4 days after reperfusion (Table) . The apparent myocardial salvage based on multidetector-CT-MaR at 120 minutes was -50.6% (ie, the infarct was 50% larger than the perfusion defect seen on multidetector-CT). At 24 hours, apparent myocardial salvage is -20.4%, and at 4 days apparent myocardial salvage is -4.8%. It is hard to explain these findings without the presence of substantial myocardial edema or inflammation from 120 minutes to ≥4 days after reperfusion.
One lesson from these studies is that infarct size and the myocardium at risk are both changing dynamically as a function of time after the MI. The imaging methods, no matter how pretty the images, report certain aspects of the pathophysiological state at a time point before or after the MI. Another lesson from the experiments conducted by Fernández-Jiménez et al 3, 4 is that one should probably do simultaneous measurements of MaR and infarct size or one is likely to introduce bias relative to the other determination. Alternatively, one could measure MaR and infarct size at times when edema is not a significant factor.
Because it is well accepted that after the MI, edema exists after reperfusion during many important time periods, the assessment of myocardial mass, MaR, and infarct size will all be different from the native characteristics before the MI. This idea is further complicated by the likelihood that the infarct has more severe edema than the salvaged myocardium. The amount of tissue swelling with reperfused MI is not trivial. The left ventricular wall thickness and apparent mass of an infarct can increase by 50%, as illustrated by the underestimations of MaR and negative values for myocardial salvage by CMR and CT at some time points in these experiments. 3 Beyond the fact that edema can modulate the estimates of MaR and infarct size, technical aspects of MRI physics may also explain the bimodal temporal course of CMR tissue characteristics after acute MI. One of the great strengths of MRI is that tissues can be characterized with imaging sequences that probe the 3 basic MRI-specific tissue parameters: T1, T2, and proton density. MRI can also be programmed to interrogate iron deposition (T2*), velocity, displacement, deformation, diffusion, and a wide variety of other parameters. Signal intensity on MR images is a complex phenomenon that requires understanding both MRI physics and the pathophysiology of the involved organ. At the same time, signal intensity on MR images has unique diagnostic value and can provide insight into pathophysiologic processes.
For example, MRI is quite useful in characterizing the age of intracranial hemorrhage, but interpreting T1 and T2 in the acute stages in this clinical setting follows a complicated temporal course, 6 with some commonalities with the bimodal response of T2 described in the heart after MI. T2-weighted images can vary from hyperintense to hypointense and back to hyperintense during the first 7 days after intracerebral bleeding.
In the heart, intramyocardial hemorrhage is common but variable in extent and severity. At the same time, the heart has substantial amounts of myoglobin that could alter T1 and T2 of recently infarcted myocardium. To tease out mechanisms for the variable time course after reperfused MRI will require more studies. It will be important to go beyond just univariable analyses based on T2. Characterization of the redox state of hemoglobin and myoglobin in the reperfused infarct may help us further understand aspects of the extent and under- Table 3 in Fernández-Jiménez et al. 3 Note that MDCT was performed in all pigs only once (during the index ischemic event).
lying status of injury and healing phase of the myocardium after acute MI.
In summary, the work by Fernández-Jiménez et al 3 is an important step forward in our understanding of the dynamic processes occurring in the first few hours and next week after MI. The human data show that the bimodal pattern of T2 abnormalities is not just an idiosyncrasy of the swine infarct model but also applies to people. That set of clinical experiments must have been ferociously difficult to perform and is not likely to be repeated anytime soon, if ever. Most of the biology will be sorted out in careful preclinical experimentation. The current swine experiments are important because they show that inconsistency of the T2-weighted CMR estimate of MaR can be quite severe, particularly 24 hours after reperfusion. However, important questions remain unanswered about how the CT-MaR can underestimate MI size without invoking myocardial edema or inflammation during the first 4 days after reperfusion.
Hopefully the work by Fernández-Jiménez et al 3 will help promote standardization in the ischemia reperfusion field and additional study of the evolution of edema, tissue swelling, and inflammation. These concepts may influence pathological measurements, imaging measurements, and even simple physiological dye injections for MaR after reperfusion. Plots of MI size versus MaR size 7 should be a standard quality assurance metric used in experiments estimating myocardial salvage. Future experiments should emphasize simultaneous measurements of both MaR and MI size and avoid comparing measurements from different time points because the measurements are intrinsically paired when making estimates of myocardial salvage, and both MaR and MI size appear to change dynamically during the first week after reperfusion. From a CMR perspective, it is critical to get beyond simply relying on T2. We need to properly characterize as many parameters that influence signal intensity and tissue appearance as feasible. Finally, CMR experts need to come to a consensus regarding when these methods should and should not be used to assess MI and myocardial salvage. 
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